Chemokine blockers – therapeutics in the making?
- 31 January 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 27 (1), 41-47
- https://doi.org/10.1016/j.tips.2005.11.001
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Multi-faceted strategies to combat disease by interference with the chemokine systemTrends in Immunology, 2005
- A Critical Role for Eosinophils in Allergic Airways RemodelingScience, 2004
- Defining a Link with Asthma in Mice Congenitally Deficient in EosinophilsScience, 2004
- CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammationJCI Insight, 2002
- The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsivenessProceedings of the National Academy of Sciences of the United States of America, 2002
- Chemokines and diseaseNature Immunology, 2001
- Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic responseThe Lancet, 2000
- Chemokines — Chemotactic Cytokines That Mediate InflammationThe New England Journal of Medicine, 1998
- ChemokinesBlood, 1997
- Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic ScalesJournal of Investigative Dermatology, 1986